Relative risk reduction versus number needed to treat as measures of lipid-lowering trial results.
Recent clinical trials dealing with cholesterol reduction in primary and secondary prevention for cardiovascular disease use Relative Risk Reduction to assess their clinical outcomes. Number Needed to Treat is a more valid measurement.